美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA204314"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
68382-792-06 68382-792 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20140910 N/A ANDA ANDA204314 Zydus Pharmaceuticals (USA) Inc. ACYCLOVIR 800 mg/1 30 TABLET in 1 BOTTLE (68382-792-06)
68382-792-10 68382-792 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20140910 N/A ANDA ANDA204314 Zydus Pharmaceuticals (USA) Inc. ACYCLOVIR 800 mg/1 1000 TABLET in 1 BOTTLE (68382-792-10)
68382-792-16 68382-792 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20140910 N/A ANDA ANDA204314 Zydus Pharmaceuticals (USA) Inc. ACYCLOVIR 800 mg/1 90 TABLET in 1 BOTTLE (68382-792-16)
68382-792-30 68382-792 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20140910 N/A ANDA ANDA204314 Zydus Pharmaceuticals (USA) Inc. ACYCLOVIR 800 mg/1 10 BLISTER PACK in 1 CARTON (68382-792-30) / 10 TABLET in 1 BLISTER PACK
66267-399-15 66267-399 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20161109 N/A ANDA ANDA204314 NuCare Pharmaceuticals, Inc. ACYCLOVIR 800 mg/1 15 TABLET in 1 BOTTLE (66267-399-15)
66267-399-21 66267-399 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20161109 N/A ANDA ANDA204314 NuCare Pharmaceuticals, Inc. ACYCLOVIR 800 mg/1 21 TABLET in 1 BOTTLE (66267-399-21)
66267-399-25 66267-399 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20161109 N/A ANDA ANDA204314 NuCare Pharmaceuticals, Inc. ACYCLOVIR 800 mg/1 25 TABLET in 1 BOTTLE (66267-399-25)
66267-399-30 66267-399 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20161109 N/A ANDA ANDA204314 NuCare Pharmaceuticals, Inc. ACYCLOVIR 800 mg/1 30 TABLET in 1 BOTTLE (66267-399-30)
66267-399-35 66267-399 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20161109 N/A ANDA ANDA204314 NuCare Pharmaceuticals, Inc. ACYCLOVIR 800 mg/1 35 TABLET in 1 BOTTLE (66267-399-35)
66267-399-50 66267-399 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20161109 N/A ANDA ANDA204314 NuCare Pharmaceuticals, Inc. ACYCLOVIR 800 mg/1 50 TABLET in 1 BOTTLE (66267-399-50)
63187-366-30 63187-366 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20160818 N/A ANDA ANDA204314 Proficient Rx LP ACYCLOVIR 800 mg/1 30 TABLET in 1 BOTTLE (63187-366-30)
63187-366-35 63187-366 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20160818 N/A ANDA ANDA204314 Proficient Rx LP ACYCLOVIR 800 mg/1 35 TABLET in 1 BOTTLE (63187-366-35)
63187-366-60 63187-366 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20160818 N/A ANDA ANDA204314 Proficient Rx LP ACYCLOVIR 800 mg/1 60 TABLET in 1 BOTTLE (63187-366-60)
63187-366-90 63187-366 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20160818 N/A ANDA ANDA204314 Proficient Rx LP ACYCLOVIR 800 mg/1 90 TABLET in 1 BOTTLE (63187-366-90)
70518-1363-0 70518-1363 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20180809 N/A ANDA ANDA204314 REMEDYREPACK INC. ACYCLOVIR 400 mg/1 15 TABLET in 1 BOTTLE, PLASTIC (70518-1363-0)
70518-1363-1 70518-1363 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20181227 N/A ANDA ANDA204314 REMEDYREPACK INC. ACYCLOVIR 400 mg/1 30 TABLET in 1 BOTTLE, PLASTIC (70518-1363-1)
70518-1363-2 70518-1363 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20260217 N/A ANDA ANDA204314 REMEDYREPACK INC. ACYCLOVIR 400 mg/1 30 TABLET in 1 BLISTER PACK (70518-1363-2)
50090-3250-0 50090-3250 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20181015 N/A ANDA ANDA204314 A-S Medication Solutions ACYCLOVIR 400 mg/1 2 TABLET in 1 BOTTLE (50090-3250-0)
50090-3250-2 50090-3250 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20171108 N/A ANDA ANDA204314 A-S Medication Solutions ACYCLOVIR 400 mg/1 25 TABLET in 1 BOTTLE (50090-3250-2)
50090-3250-3 50090-3250 HUMAN PRESCRIPTION DRUG acyclovir acyclovir TABLET ORAL 20171108 N/A ANDA ANDA204314 A-S Medication Solutions ACYCLOVIR 400 mg/1 50 TABLET in 1 BOTTLE (50090-3250-3)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2026 Drugfuture->U.S. FDA National Drug Code DataBase